Cipher Pharmaceuticals Inc (TSX:CPH)

C$ 14.74 0.08 (0.55%) Market Cap: 377.19 Mil Enterprise Value: 422.08 Mil PE Ratio: 17.35 PB Ratio: 2.83 GF Score: 75/100

Q3 2024 Cipher Pharmaceuticals Inc Earnings Call Transcript
Nov 08, 2024

C$13.88 (-10.68%)

Earnings
Q1 2024 Cipher Pharmaceuticals Inc Earnings Call Transcript
May 10, 2024

C$9.25 (+3.35%)

Earnings
Q4 2023 Cipher Pharmaceuticals Inc Earnings Call Transcript
Mar 15, 2024

C$8.1 (+13.60%)

Earnings
Q3 2023 Cipher Pharmaceuticals Inc Earnings Call Transcript
Nov 10, 2023

C$5.15 (+14.19%)

Earnings
Q2 2023 Cipher Pharmaceuticals Inc Earnings Call Transcript
Aug 11, 2023

C$3.44 (-3.37%)

Earnings
Q1 2023 Cipher Pharmaceuticals Inc Earnings Call Transcript
May 12, 2023

C$3.5 (+9.03%)

Earnings
Q4 2022 Cipher Pharmaceuticals Inc Earnings Call Transcript
Mar 17, 2023

C$3.6 (-4.00%)

Earnings
Cipher Pharmaceuticals Inc at Issuer Direct Planet MicroCap Showcase (Virtual) Transcript
Dec 07, 2022
Q3 2022 Cipher Pharmaceuticals Inc Earnings Call Transcript
Nov 11, 2022

C$3.37 (-5.60%)

Earnings
Q2 2022 Cipher Pharmaceuticals Inc Earnings Call Transcript
Aug 12, 2022

C$2.31

Earnings
Cipher Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Jun 22, 2022
Q1 2022 Cipher Pharmaceuticals Inc Earnings Call Transcript
May 13, 2022

C$2.5 (+6.38%)

Earnings
Q4 2021 Cipher Pharmaceuticals Inc Earnings Call Transcript
Mar 18, 2022

C$2.44 (+12.96%)

Earnings
Q3 2021 Cipher Pharmaceuticals Inc Earnings Call Transcript
Nov 12, 2021

C$2.13 (-16.80%)

Earnings
Q2 2021 Cipher Pharmaceuticals Inc Earnings Call Transcript
Aug 13, 2021

C$2.02 (+20.96%)

Earnings
Cipher Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Jun 23, 2021
Q1 2021 Cipher Pharmaceuticals Inc Earnings Call Transcript
May 14, 2021

C$1.41 (-11.88%)

Earnings
Q4 2020 Cipher Pharmaceuticals Inc Earnings Call Transcript
Mar 19, 2021

C$1.12 (+20.43%)

Earnings
Q3 2020 Cipher Pharmaceuticals Inc Earnings Call Transcript
Nov 13, 2020

C$0.92 (-7.07%)

Earnings
Cipher Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Oct 08, 2020
Q2 2020 Cipher Pharmaceuticals Inc Earnings Call Transcript
Aug 13, 2020

C$1.29 (-7.19%)

Earnings
Q1 2020 Cipher Pharmaceuticals Inc Earnings Call Transcript
May 08, 2020

C$1.19 (+32.22%)

Earnings
Q4 2019 Cipher Pharmaceuticals Inc Earnings Call Transcript
Mar 26, 2020

C$0.7 (+66.67%)

Earnings
Q3 2019 Cipher Pharmaceuticals Inc Earnings Call Transcript
Nov 07, 2019

C$1.16 (-7.20%)

Earnings
Q2 2019 Cipher Pharmaceuticals Inc Earnings Call Transcript
Aug 09, 2019

C$1.23

Earnings
Q1 2019 Cipher Pharmaceuticals Inc Earnings Call Transcript
May 10, 2019

C$1.46 (+2.82%)

Earnings
Q4 2018 Cipher Pharmaceuticals Inc Earnings Call Transcript
Mar 19, 2019

C$1.68 (-7.69%)

Earnings

Cipher Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 22, 2022 / 02:00PM GMT

Release Date Price: C$2.3

Transcript

Operator

Hello, and welcome to the Annual General and Special Meeting of Shareholders of Cipher Pharmaceuticals, Inc. Please note that today's meeting is being recorded. (Operator Instructions)

It is now my pleasure to turn today's meeting over to Craig Mull, Interim Chief Executive Officer of Cipher Pharmaceuticals. The floor is yours.

Craig J. Mull

Cipher Pharmaceuticals Inc. - Interim CEO & Chairman of the Board

Good morning, ladies and gentlemen, and welcome to Cipher's Annual and Special Meeting of Shareholders. My name is Craig Mull, and I am the Chairman and Interim Chief Executive Officer of Cipher Pharmaceuticals, and I will act as Chairman of the meeting.

As this meeting is being held virtually by way of a live webcast, we think it is necessary to set out a few rules for orderly conduct of the meeting. Firstly, questions in respect of the motion can be submitted by any registered shareholder or duly appointed proxy holder by clicking on the Q&A icon on the virtual interface at any time.

Secondly, when asking a question,

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.